Articles from Sequel

The webinar category was built to run webinars. Sequel.io believes its next chapter will be defined by what happens because of them.

Sequel has announced a partnership with the New York Yankees to provide complimentary feminine hygiene products at Yankee Stadium, continuing the organization’s commitment to enhancing the fan experience through thoughtful, inclusive amenities.

Sequel has been named as the Official Tampon Partner of the Indiana Fever, it was announced today. As part of the partnership, Sequel products will be available to both Fever players and fans, with complimentary Spiral Tampons available in the team’s locker room and throughout Gainbridge Fieldhouse restrooms.

Sequel, a startup, dedicated to engineering better health and wellness experiences for women, today announced that its breakthrough spiral tampon has received approval from the United States Food and Drug Administration (FDA) as a medical device. Approval from the FDA marks a critical step in enabling Sequel to bring its tampon–which is designed to be more comfortable and less prone to leakage–to market and reinvigorate a space that has been flooded with private label newcomers, but little product differentiation.

Sequel, a startup engineering better health and wellness experiences for women starting with a leakage-preventing tampon, launched today and announced that it has raised $5 million in seed funding. Founded by two high-level athletes and Stanford engineers, Sequel’s mission is to raise the standard of women’s products with better design and superior technology. This funding will fuel Sequel as the company brings its first novel product to market, reinvigorating a space that has not seen innovation for 80 years. MaC VC, Pear Accelerator, Long Journey Ventures, Ulu Ventures, Graph Ventures and other strategic angels, including Cyan Banister and Nurx CEO Varsha Rao, contributed to this round.